PWE-050 Follow-on rifaximin for the prevention of recurrence in clostridium difficile associated diarrhoea: a randomised controlled trial
Giles Major(University Hospital of Lausanne), Alan Montgomery(University of Nottingham), Mathew Diggle(Nottingham University Hospitals NHS Trust), Kirsty Sprange(University of Nottingham), Lucy Bradshaw(University of Nottingham), Nafisa Boota(University of Leicester), Robert E. Spiller(Nottingham University Hospitals NHS Trust), Aida Jawhari(Nottingham University Hospitals NHS Trust)
Cited by 0
Related Papers
Functional Bowel Disorders
|Gastroenterology|2006|4.8k
Bowel Disorders
|Gastroenterology|2016|2.8k
Postinfectious Irritable Bowel Syndrome
|Gastroenterology|2009|1k
Irritable bowel syndrome
|Nature Reviews Disease Primers|2016|981